Q4 2025 Quarterly Report on Commercially Available Kava Products

Prepared by: Douglas La Rose, Executive Director

The Kava Coalition’s newly released Q4 2025 Market Survey shows clear progress in the quality and safety of commercially available kava products, with 73% meeting microbial safety action limits, up from 49% in Q1 2025. Independent testing of 40 products found no detectable heavy metals, pesticides, mycotoxins, or residual solvents, and confirmed the presence of authentic noble kava chemotypes. While the results point to growing adoption of stronger standards, ongoing microbial challenges highlight why continued testing and transparency remain critical, read the full report to see what’s improving and where the industry still needs to act.